Trial intelligence / Profile preview

Stem cell therapy for patients with flaccid bladder

RBR-10bk2qbbCompleted

Sponsor
Universidade Federal de Mato Grosso do Sul
Start
Oct 2019
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Randomised, open-label trial of autologous adipose-derived mesenchymal stromal cells in Detrusor hypocontractility (2 arms), sponsored by Universidade Federal de Mato Grosso do Sul. Started Oct 2019; status: completed.

02

Drugs

autologous adipose-derived mesenchymal stromal cells
03

Conditions

Detrusor hypocontractility

Beyond the preview

Go deeper on RBR-10bk2qbb.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-10bk2qbb.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call